IGF1 and cancer: In addition to pharmacological agents targeting insulin/IGFRs or ligands, including emerging work on microRNA-based approaches (182), a wide variety of natural agents with demonstrated cancer chemopreventive or chemotherapeutic activity have recently been reported to target components of the insulin/IGF pathway (183).